Adjuvant intravesical therapy and improved survival among elderly patients with superficial bladder cancer

被引：2
|
作者：
Spencer, Benjamin A.
Mohile, Supriya G.
Hershman, Dawn
Wang, Jian
Herr, Harry W.
Benson, Mitchell C.
Neugut, Alfred I.
机构：
来源：
JOURNAL OF UROLOGY | 2007年 / 177卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)31759-2
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：519 / 519
页数：1
相关论文
共 50 条
  • [21] Intravesical immunotherapy for superficial bladder cancer
    Said, MT
    Abomelha, MS
    Orkubi, SA
    SAUDI MEDICAL JOURNAL, 2002, 23 (12) : 1458 - 1461
  • [22] Intravesical chemotherapy for superficial bladder cancer
    J Alfred Witjes
    Frans MJ Debruyne
    Nature Clinical Practice Urology, 2004, 1 (2): : 56 - 57
  • [23] Intravesical chemotherapy for superficial bladder cancer
    Witjes, JA
    Debruyne, FMJ
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (04): : A56 - A57
  • [24] Intravesical immunotoxin as adjuvant therapy to prevent the recurrence of bladder cancer
    Zhang, ZJ
    Xu, HY
    Yu, LZ
    Yang, DL
    Xie, SS
    Shi, YF
    Li, ZH
    Li, JM
    Wang, JS
    Li, ML
    Guo, YL
    Gu, FL
    CHINESE MEDICAL JOURNAL, 2000, 113 (11) : 1002 - 1006
  • [25] Adjuvant intravesical therapy based on an in vitro cytotoxicity assay in the management of superficial transitional cell cancer of the urinary bladder
    Saxena, Sunita
    Agrawal, Usha
    Agarwal, Abhilasha
    Murthy, Nandagudi Srinivasa
    Mohanty, Nayan Kumar
    BJU INTERNATIONAL, 2006, 98 (05) : 1012 - 1017
  • [26] Intravesical immunotoxin as adjuvant therapy to prevent the recurrence of bladder cancer
    臧智江
    徐鸿毅
    俞莉章
    杨德林
    谢蜀生
    石永福
    李泽惠
    李炯明
    王剑松
    李玛琳
    郭应禄
    顾方六
    中华医学杂志(英文版), 2000, (11) : 42 - 46
  • [27] Intravesical immunotoxin as adjuvant therapy to prevent the recurrence of bladder cancer
    臧智江
    徐鸿毅
    俞莉章
    杨德林
    谢蜀生
    石永福
    李泽惠
    李炯明
    王剑松
    李玛琳
    郭应禄
    顾方六
    Chinese Medical Journal, 2000, (11)
  • [28] Our Experience with the Management of Superficial Bladder Cancer (Transitional Cell Ca), the Role of Adjuvant intravesical BCG Therapy
    Shah, S.
    Tarar, K. D.
    Bhatti, S. U.
    Suhaib, S.
    ANNALS OF KING EDWARD MEDICAL UNIVERSITY LAHORE PAKISTAN, 2006, 12 (04): : 550 - 552
  • [29] PHARMACOKINETICS OF INTRAVESICAL DOXORUBICIN IN SUPERFICIAL BLADDER-CANCER PATIENTS
    CHAI, M
    WIENTJES, MG
    BADALAMENT, RA
    BURGERS, JK
    AU, JLS
    JOURNAL OF UROLOGY, 1994, 152 (02): : 374 - 378
  • [30] A phase II study of intravesical gemcitabine as adjuvant therapy in patients (pts) with superficial bladder carcinoma: final results
    Bounedjar, A.
    Ferhat, R.
    Bouzid, K.
    EJC SUPPLEMENTS, 2005, 3 (02): : 249 - 249
12345